4th Quarter - Report
AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144); drug safety issues; prescription drug abuse; Senate HELP Committee's Innovation Working Group;
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
Copyright/Patent/Trademark CPT
H.R. 9, Innovation Act; S. 1137, PATENT Act; S. 779, Fair Access to Science & Technology Research Act of 2015
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
| AMY TEJRAL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.